Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 9/2016

01-09-2016 | Infection (J Halperin, Section Editor)

Impact of Infection on Stroke Morbidity and Outcomes

Authors: Chad M. Miller, Réza Behrouz

Published in: Current Neurology and Neuroscience Reports | Issue 9/2016

Login to get access

Abstract

Each year, millions of persons worldwide are disabled by stroke. The burden of stroke is expected to increase as a consequence of growth in our elderly population. Outcome is dependent upon limitation of secondary medical processes in the acute setting that lead to deterioration and increased long-term disability. The prevalence of infection after stroke is greater that seen in other medical conditions with similar acuity and its impact upon morbidity and mortality is substantial. Physical impairment and immune modulation are chief determinants in rate of infection after stroke. Each of these factors has been a target for therapeutic intervention. Current best practices for acute stroke management implement strategies for prevention, prompt identification, and treatment of infection. Novel therapies are currently being explored which have the opportunity to greatly minimize infectious complications following stroke. Fever commonly accompanies infection and independently influences stroke outcome. Targeted temperature management provides an additional chance to improve stroke recovery.
Literature
1.
Shim R, Wong CH. Ischemia, immunosuppression and infection, tackling the predicaments of post-stroke complications. Int J Mol Sci. 2016;17:64.CrossRefPubMedCentral
2.
Yeh SJ, Huang KY, Wang TG, et al. Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit. J Neurol Sci. 2011;306:38–41.CrossRefPubMed
3.
Bustamante A, Garcia-Berrocoso T, Rodriguez N, et al. Ischemic stroke outcome: a review of the influence of post-stroke complications within the different scenarios of stroke care. Eur J Int Med. 2016;29:9–21.CrossRef
4.
Friedant A, Gouse BM, Boehme A, et al. A simple prediction score for developing a hospital-acquired infection after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2015;34(3):680–6.CrossRef
5.
Teramoto S. Novel preventive and therapeutic strategy for post-stroke pneumonia. Expert Rev Neurother. 2009;9:1187–200.CrossRefPubMed
6.
Brogan E, Langdon C, Brookes K, Budgeon C, Blacker D. Respiratory infections in acute stroke: nasogastric tubes and immobility are stronger predictors than dysphagia. Dysphagia. 2014;29:340–5.CrossRefPubMed
7.
8.
Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke. 2006;37:2607–12.CrossRefPubMed
9.
10.
Doll DN, Engler-Chiurazzi BE, Lewis SE, et al. Lipopolysaccharide exacerbates infarct size and results in worse post-stroke behavioral outcomes. Behav Brain Funct. 2015;11:32.CrossRefPubMedPubMedCentral
11.
Kenes A, Pradillo JM, Drake C, et al. Streptococcus pneumonia worsens cerebral ischemia via interleukin 1 and platelet glycoprotein Ibα. Ann Neurol. 2014;75:670–83.CrossRef
12.
Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26:654–5.CrossRefPubMed
13.
14.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.CrossRef
15.•
Boehme AK, Kumar AD, Dorsey AM, et al. Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients. J of Stroke and Cerebrov Dis. 2013;22(8):e582–9. This trial identified the specific detriment posed by infection in the early days after stroke and compared it to the lesser impact of pre-existing stroke.CrossRef
16.••
Shah SV, Corado C, Bergman D, et al. Impact of poststroke medical complications on 30-day readmission rate. J of Stroke and Cerebrov Dis. 2015;24(9):1969–77. This study highlights the incidence and impact of hospital complications upon readmission rate after stroke. These findings may prove pivotal in clinical strategies to lower readmission rate and optimize long-term recovery.CrossRef
17.•
Ji R, Wang D, Shen H, et al. Interrelationship among common medical complications after acute stroke. Stroke. 2013;44:3436–44. This study showed that not only is infection prevalent after ischemic stroke but also the presence of infection increases the risk for other post-stroke medical comorbidities.CrossRefPubMed
18.
Berger B, Gumbinger C, Steiner T, et al. Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unit. J of Crit Care. 2014;29:241–8.CrossRef
19.
Westendorp WF, Vermeij J, Zock E, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomized open-label masked endpoint clinical trial. Lancet. 2015;385:1519–26.CrossRef
20.
Laban KG, Rinkel GJ, Vergouwen MDI. Nosocomial infections after aneurysmal subarachnoid hemorrhage: time course and causative pathogens. Int J Stroke. 2015;10:763–6.CrossRefPubMed
21.
22.
Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;19:725–36.CrossRef
23.
Hannawi Y, Hannaw B, Rao CP, et al. Stroke-associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35:430–3.CrossRefPubMed
24.
Dziedzic T, Slowik A, Pera J, et al. B-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci. 2007;252:53–6.CrossRefPubMed
25.
Sykora M, Siarnik P, Diedler J, et al. B-Blockers, pneumonia, and outcome after ischemic stroke. Stroke. 2015;46:1269–74.CrossRefPubMed
26.
Wong CH, Jenne CN, Lee WY, et al. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334:101–5.CrossRefPubMed
27.••
Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. This comprehensive guideline includes instruction on minimizing and treating infection occurring after stroke. While many new strategies for limiting post-stroke infection are being explored, this manuscript represents current best practice.CrossRefPubMed
28.•
Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcomes. Stroke. 2000;31:410–4. Fever has traditionally been accepted as a marker of injury severity. This study demonstrates that fever is independently associated with poor outcome after stroke.CrossRefPubMed
29.
Mrozek S, Vardon F, and Geeraerts T. Brain temperature: physiology and pathophysiology after brain injury. Anesthesiol Res Pract. 2012. doi:10.​1155/​2012/​989487.
30.
Schreskinger M, Marion DW. Contemporary management of traumatic intracranial hypertension: is there a role for therapeutic hypothermia? Neurocrit Care. 2009;11:427–36.CrossRef
31.
Lanier WL. Cerebral metabolic rate and hypothermia: their relationship with ischemic injury. J Neurosurg Anesthesiol. 1995;7(3):216–21.CrossRefPubMed
32.
Polderman KH. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet. 2008;371:1955–69.CrossRefPubMed
33.
Badjatia N. Fever control in the NeuroICU: why, who and when? Crit Care Med. 2009;15:79–82.
34.
Metadata
Title
Impact of Infection on Stroke Morbidity and Outcomes
Authors
Chad M. Miller
Réza Behrouz
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 9/2016
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-016-0679-9

Other articles of this Issue 9/2016

Current Neurology and Neuroscience Reports 9/2016 Go to the issue

Behavior (H Kirshner, Section Editor)

A Neuropsychological Perspective on Abstract Word Representation: From Theory to Treatment of Acquired Language Disorders

Epilepsy (CW Bazil, Section Editor)

Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide

Behavior (H Kirshner, Section Editor)

Anosognosia in Dementia

Sleep (M Thorpy and M Billiard, Section Editors)

Sleep Disturbances in Frontotemporal Dementia

Demyelinating Disorders (DN Bourdette and M Cameron, Section Editors)

Alemtuzumab for Multiple Sclerosis

Critical Care (SA Mayer, Section Editor)

ICU Management of the Potential Organ Donor: State of the Art